2 assets in Cervical Small Cell Carcinoma

Therapeutic assets addressing Cervical Small Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cis-Diamminedichloroplatinum Ii Cervical Small Cell Carcinoma	Uganda Cancer Institute	P2	BB (64)
1-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-4-(4-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)-4-PIPERIDINOL Cervical Small Cell Carcinoma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1/2	CCC (48)